Lipschitz Shirley
Dr Shirley Lipschitz and Associates, Sunninghill, Sandton, South Africa.
SA J Radiol. 2018 Oct 31;22(2):1370. doi: 10.4102/sajr.v22i2.1370. eCollection 2018.
Screening mammography is known to reduce mortality from breast cancer. Controversy regarding screening has led to much confusion in the medical fraternity. The purpose of this review is to point out the 'pros and cons' of screening. The benefits and perceived harms of screening will be discussed using evidence-based literature from the past 30 years. The literature was obtained from various journals sourced from the Internet. General findings are that screening mammography from the age of 40 saves lives, but that the problem of overdiagnosis and overtreatment of certain breast cancers overrides the benefit of screening. The article also covers the debate on what age to begin screening. Screening in the South African context is discussed. Screening in the future will need to be more selective of patients and of which cancers to treat less aggressively, if at all.
已知乳腺钼靶筛查可降低乳腺癌死亡率。关于筛查的争议在医学界引发了诸多困惑。本综述的目的是指出筛查的“利弊”。将利用过去30年的循证文献讨论筛查的益处和潜在危害。这些文献来自从互联网获取的各种期刊。总体研究结果是，40岁开始的乳腺钼靶筛查可挽救生命，但某些乳腺癌的过度诊断和过度治疗问题超过了筛查的益处。本文还涵盖了关于从什么年龄开始筛查的争论。讨论了南非背景下的筛查情况。未来的筛查将需要更有选择性地针对患者以及更有选择性地针对哪些癌症采取不那么积极的治疗措施（如果确实要治疗的话）。
